[Protocol for optimal therapy of malignant melanoma in the metastatic stage by the Dermatologic Oncology Working Group].
Hauschild
A
A
Universitäts-Hautklinik, Kiel.
D003131:Combined Modality Therapy; D003606:Dacarbazine / Q000008:administration & dosage*; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage*; D007376:Interleukin-2 / Q000008:administration & dosage / Q000031:analogs & derivatives*; D008545:Melanoma / Q000473:pathology / Q000628:therapy*; D009367:Neoplasm Staging; D011446:Prospective Studies; D011994:Recombinant Proteins / Q000008:administration & dosage; D012878:Skin Neoplasms / Q000473:pathology / Q000628:therapy*
D016898:Interferon-alpha; D007376:Interleukin-2; D011994:Recombinant Proteins; D003606:Dacarbazine; C082598:aldesleukin